Levofloxacin-containing triple therapy versus bismuthbased quadruple therapy as regimens for second line anti-Helicobacter pylori

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SEYYEDMAJIDI MOHAMMADREZA; ABBASI LALEH; Seyed Majidi Seyed ali; Seyed Ashkan Seyed Ashkan; Ahmadi Anahita; Hajiebrahimi Shahin; VAFAEIMANESH JAMSHID

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Caspian Journal of Internal Medicine Year:2019 | Volume:10 | Issue:2 Page(s): 211-216

Download Full-Text

View:

155

Download:

Cites:

Information Journal Paper

Title

Levofloxacin-containing triple therapy versus bismuthbased quadruple therapy as regimens for second line anti-Helicobacter pylori

Author(s)

Keywords

Helicobacter pylori;Second

line Therapy;Levofloxacin

based triple therapy;Bismuth

based quadruple therapy

Abstract

Background: Although the prevalence of Helicobacter pylori infection decreased following the hygiene promotion and application of proper anti-H. pylori treatments, unfortunately gradual increase is reported in treatment failure; hence, application of a proper treatment regimen as a second-line therapy is of great importance. Methods: In the current randomized, clinical trial, a total of 120 patients with peptic ulcers who failed to respond to treatment were enrolled. In the OLA group, a regimen of omeprazole 40 mg/day, levofloxacin 1 g/day, and amoxicillin 2 g/ day was prescribed; however, a regimen of omeprazole 40 mg/day, bismuth sub-citrate 480 mg/day, furazolidone 400 mg/day, and amoxicillin 2 g/day was administered to the OFAB group. Both groups were treated for 2 weeks, and 6 weeks after the treatment, the urea breath test (UBT) was performed in the subjects. Collected data were analyzed with SPSS Version 18. At the end, 58 patients in group OLA and 57 patients in the OFAB group were analyzed. Results: According to the results of the current study, 96. 7% of the subjects in the OLA and 95% in the OFAB groups completed the treatment course and the eradication rates were 86. 7% and 78. 3% in the OLA and OFAB groups, respectively (P=0. 23). Treatment side effects were observed in 51. 7% and 11. 7% of the subjects in the OLA and OFAB groups, respectively (P<0. 01). Conclusion: Both regimens were applicable as the second-line therapy due to insignificant difference between the results of the 2 groups; however, OLA regimen was superior to OFAB, due to lower side effects.

Cites

No record.

References

Cite

APA: Copy

SEYYEDMAJIDI, MOHAMMADREZA, ABBASI, LALEH, Seyed Majidi, Seyed ali, Seyed Ashkan, Seyed Ashkan, Ahmadi, Anahita, Hajiebrahimi, Shahin, & VAFAEIMANESH, JAMSHID. (2019). Levofloxacin-containing triple therapy versus bismuthbased quadruple therapy as regimens for second line anti-Helicobacter pylori. CASPIAN JOURNAL OF INTERNAL MEDICINE, 10(2), 211-216. SID. https://sid.ir/paper/323647/en

Vancouver: Copy

SEYYEDMAJIDI MOHAMMADREZA, ABBASI LALEH, Seyed Majidi Seyed ali, Seyed Ashkan Seyed Ashkan, Ahmadi Anahita, Hajiebrahimi Shahin, VAFAEIMANESH JAMSHID. Levofloxacin-containing triple therapy versus bismuthbased quadruple therapy as regimens for second line anti-Helicobacter pylori. CASPIAN JOURNAL OF INTERNAL MEDICINE[Internet]. 2019;10(2):211-216. Available from: https://sid.ir/paper/323647/en

IEEE: Copy

MOHAMMADREZA SEYYEDMAJIDI, LALEH ABBASI, Seyed ali Seyed Majidi, Seyed Ashkan Seyed Ashkan, Anahita Ahmadi, Shahin Hajiebrahimi, and JAMSHID VAFAEIMANESH, “Levofloxacin-containing triple therapy versus bismuthbased quadruple therapy as regimens for second line anti-Helicobacter pylori,” CASPIAN JOURNAL OF INTERNAL MEDICINE, vol. 10, no. 2, pp. 211–216, 2019, [Online]. Available: https://sid.ir/paper/323647/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops